Drugs / Carmustin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00647049 | Jan 2007 → May 2013 | primary central nervous system lymphoma | University Hospital Freiburg | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Carmustin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00647049 ↗ |
| Route | Intravenous | “400mg/m2 i.v. for 1 day” NCT00647049 ↗ |